Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Pediatric Neurology · Focal Cortical Dysplasia

Treatment Strategies: From Medication to Surgery

At a Glance

For children with focal cortical dysplasia, medication comes first, but seizures continuing after one or two appropriate medicines warrant early evaluation at a comprehensive epilepsy center. Surgery offers the best chance of seizure freedom when abnormal tissue can be safely removed.

When your child is diagnosed with Focal Cortical Dysplasia (FCD), the focus shifts from “what is it?” to “how do we stop the seizures?”

Because FCD is a structural issue—a physical “misfiring” spot in the brain—it often behaves differently than other types of epilepsy. Standard care usually begins with medication, but for many families, the most effective path forward involves a specialized surgical evaluation [1][2].

The Limits of Medication: Diminishing Returns

Most children with FCD will try anti-seizure medications (ASMs) first. Drug-resistant epilepsy is usually defined as the failure of two appropriate, tolerated medication regimens. Research shows that if the first one or two medications do not stop the seizures, the chance of a third or fourth drug providing complete freedom is very low [2].

In one study of a highly selected pediatric FCD cohort:

  • Only about 7% achieved seizure freedom with a second medication [2].
  • Fewer than 6% found success with a third or later medication [2].

Because of these “diminishing returns,” many experts now recommend an Early Surgical Evaluation. Instead of waiting years for multiple medications to fail, families are encouraged to consult a Comprehensive Epilepsy Center after just one or two failed trials [2][1]. Early seizure control is vital for protecting a child’s developing brain and cognitive potential [3]. (Note: Never stop or change medications without your doctor’s guidance.)

Surgical Options: Resection and Ablation

Surgery is currently a major pathway to achieve long-term seizure freedom for children with FCD. The goal is the complete resection (removal) of the abnormal brain tissue [4].

  • Resective Surgery: This is the traditional approach where a surgeon removes the dysplastic area. In selected surgical cohorts, about 60-70% achieve freedom from disabling seizures (Engel Class I) after surgery [5][6]. Success rates depend heavily on localization, completeness of resection, and the specific lesion type.
  • Laser Interstitial Thermal Therapy (LITT): This is a less invasive “ablation” technique. A surgeon uses a thin laser probe to heat and destroy the abnormal tissue without a large incision [6]. LITT has its own risks, may incompletely treat diffuse FCD, and has a less mature pediatric evidence base than traditional resection [7][6].

Material Risks of Brain Surgery:
Consent for brain surgery requires balancing the benefits against serious material risks. Depending on the brain area treated, these may include permanent weakness, language or vision deficits, memory effects, bleeding, infection, anesthesia complications, and the possibility of persistent seizures despite the procedure.

Seizure-Reducing Treatments

In some cases, the FCD may be in a “no-go” zone (an eloquent area responsible for movement or speech), or it may involve multiple areas of the brain. If complete removal is too risky, the goal shifts to seizure-reducing treatments designed to reduce the frequency and severity of seizures.

  • Neuromodulation: These are “pacemaker-like” devices for the brain.
    • Vagus Nerve Stimulation (VNS): A device implanted in the chest that sends regular pulses to the brain via the vagus nerve. About half of children see a 50% or greater reduction in seizures [8].
    • Responsive Neurostimulation (RNS): A device that monitors brainwaves and sends a pulse to interrupt abnormal activity. While RNS is FDA-approved for adults with focal epilepsy, pediatric use is generally off-label, investigational, and depends on local center expertise [9][10].
  • Ketogenic Diet: This high-fat, low-carbohydrate medical diet can be very effective for some children with structural epilepsy like FCD [11]. It requires strict medical supervision and can help reduce seizures by changing how the brain uses energy [12].

While these options rarely provide total seizure freedom, they can significantly improve a child’s quality of life and reduce the burden of seizures [13][14].

Common questions in this guide

When should a child with FCD be evaluated for epilepsy surgery?
A child may be considered for evaluation at a comprehensive epilepsy center after one or two appropriate medicines fail to control seizures. Failure of two appropriate, tolerated medication regimens is commonly used to define drug-resistant epilepsy, and an evaluation does not automatically mean the child will have surgery.
How effective is surgery for focal cortical dysplasia?
In selected pediatric surgical groups, about 60% to 70% of children became free from disabling seizures after resective surgery. The chance of success depends on finding the seizure focus, removing all of the abnormal tissue safely, and the type of focal cortical dysplasia.
What is LITT, and can it replace traditional surgery for FCD?
Laser interstitial thermal therapy uses a thin laser probe to heat and destroy abnormal brain tissue through a smaller access point than traditional resection. It may be appropriate for some children, but it has its own risks, may not fully treat diffuse FCD, and has less established pediatric evidence than resection.
What treatments can reduce seizures if the abnormal tissue cannot be safely removed?
Vagus nerve stimulation can reduce seizures by sending regular electrical pulses through the vagus nerve, and a ketogenic diet may help some children. Responsive neurostimulation monitors brain activity and can interrupt abnormal signals, but pediatric use is generally off-label or investigational and depends on specialized center experience.
What does drug-resistant epilepsy mean for a child with FCD?
Drug-resistant epilepsy generally means that two appropriate and tolerated anti-seizure medication regimens have failed to stop the seizures. Because later medications are less likely to provide complete seizure control, families are often encouraged to discuss early evaluation at a comprehensive epilepsy center.

Get notified when new evidence is published on Isolated focal cortical dysplasia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (14)
  1. 1

    Children with seizures and radiological diagnosis of focal cortical dysplasia: can drug-resistant epilepsy be predicted earlier?

    Zvi IB, Enright N, D'arco F, et al.

    Epileptic disorders : international epilepsy journal with videotape 2022; (24(1)):111-122 doi:10.1684/epd.2021.1368.

    PMID: 34750096
  2. 2

    Prevalence and Risk Factors for Pharmacoresistance in Children With Focal Cortical Dysplasia-Related Epilepsy.

    Cohen NT, Chang P, You X, et al.

    Neurology 2022; (99(18)):e2006-e2013 doi:10.1212/WNL.0000000000201033.

    PMID: 35985831
  3. 3

    Expedited epilepsy surgery prior to drug resistance in children: a frontier worth crossing?

    Hale AT, Chari A, Scott RC, et al.

    Brain : a journal of neurology 2022; (145(11)):3755-3762 doi:10.1093/brain/awac275.

    PMID: 35883201
  4. 4

    Seizure Outcome After Surgery for MRI-Diagnosed Focal Cortical Dysplasia: A Systematic Review and Meta-analysis.

    Willard A, Antonic-Baker A, Chen Z, et al.

    Neurology 2022; (98(3)):e236-e248 doi:10.1212/WNL.0000000000013066.

    PMID: 34893558
  5. 5

    Surgical outcome and predictive factors of epilepsy surgery in pediatric isolated focal cortical dysplasia.

    Choi SA, Kim SY, Kim H, et al.

    Epilepsy research 2018; (139()):54-59 doi:10.1016/j.eplepsyres.2017.11.012.

    PMID: 29197666
  6. 6

    A comparison between magnetic resonance-guided laser interstitial thermal therapy and resective surgery for drug-resistant epilepsy in patients with MRI-positive focal cortical dysplasia: A systematic review and meta-analysis.

    Haro-Perez PS, Saltos-Ponce FA, Del Valle-Lascano CD, et al.

    Epilepsy research 2025; (218()):107660 doi:10.1016/j.eplepsyres.2025.107660.

    PMID: 40946535
  7. 7

    Laser interstitial thermal therapy for refractory epilepsy in children under 2 years: A single-center case series and review of the literature.

    Ramani PK, El Ghawi O, Beltz B, et al.

    Epileptic disorders : international epilepsy journal with videotape 2026; (28(4)):1141-1149 doi:10.1002/epd2.70260.

    PMID: 42041230
  8. 8

    Efficacy of vagus nerve stimulation in 95 children of drug-resistant epilepsy with structural etiology.

    Xie H, Ma J, Ji T, et al.

    Epilepsy & behavior : E&B 2023; (140()):109107 doi:10.1016/j.yebeh.2023.109107.

    PMID: 36758359
  9. 9

    A Scoping Review of Responsive Neurostimulation in Focal Cortical Dysplasia-Related Epilepsy.

    Chang V, Reeders PC, Blackwood ER, et al.

    Epilepsy & behavior : E&B 2025; (166()):110362 doi:10.1016/j.yebeh.2025.110362.

    PMID: 40081147
  10. 10

    Invasive Neuromodulation of Drug-Resistant Epilepsy in Pediatric Populations: A Comprehensive Systematic Review and Meta-Analysis.

    Zaidan SK, Ghaith HS, Abdelkader K, et al.

    Neuromodulation : journal of the International Neuromodulation Society 2026; doi:10.1016/j.neurom.2026.06.477.

    PMID: 42663589
  11. 11

    Efficacy of the Ketogenic Diet for Pediatric Epilepsy According to the Presence of Detectable Somatic mTOR Pathway Mutations in the Brain.

    Ko A, Sim NS, Choi HS, et al.

    Journal of clinical neurology (Seoul, Korea) 2022; (18(1)):71-78 doi:10.3988/jcn.2022.18.1.71.

    PMID: 35021279
  12. 12

    Diagnostic methods and treatment options for focal cortical dysplasia.

    Guerrini R, Duchowny M, Jayakar P, et al.

    Epilepsia 2015; (56(11)):1669-86 doi:10.1111/epi.13200.

    PMID: 26434565
  13. 13

    Comparative multicenter evaluation of thalamic neuromodulation for treatment-resistant epilepsy in children.

    Tenhoeve SA, Warsi NM, Ludwick AM, et al.

    Epilepsia 2026; (67(10)):5201-5214 doi:10.1002/epi.70402.

    PMID: 42501045
  14. 14

    Responsive neurostimulation of thalamic nuclei for regional and multifocal drug-resistant epilepsy in children and young adults.

    Mohanty D, Houck KM, Trandafir C, et al.

    Journal of neurosurgery. Pediatrics 2024; (34(1)):40-48 doi:10.3171/2024.2.PEDS23531.

    PMID: 38608307

This page explains treatment options for children with focal cortical dysplasia for informational purposes only and does not replace medical advice. A pediatric neurologist or epilepsy surgery team should guide decisions about medication, diet, or surgery.